Brief: Allarity Therapeutics - On July 19, Co Received A "Wells Notice" From Staff Of U.S. SEC Relating To Co's Previously Disclosed SEC Investigation
July 22 (Reuters) - Allarity Therapeutics Inc ALLR.O :
* ALLARITY THERAPEUTICS - ON JULY 19, CO RECEIVED A "WELLS
NOTICE" FROM STAFF OF U.S. SEC RELATING TO CO'S PREVIOUSLY
DISCLOSED SEC INVESTIGATION
* ALLARITY THERAPEUTICS - CO UNDERSTANDS THAT ALL CONDUCT
RELATING
TO SEC WELLS NOTICE OCCURRED DURING OR PRIOR TO FISCAL YEAR 2022
* ALLARITY THERAPEUTICS: NOTICE SAID SEC STAFF MADE PRELIM
DETERMINATION TO RECOMMEND ENFORCEMENT ACTION AGAINST CO TO
ALLEGE SOME VIOLATIONS OF LAWS
Source text for Eikon: ID:n0001213900-24-063201
Further company coverage: ALLR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Allarity Therapeutics
See all newsBrief: Allarity Therapeutics Announces Strategic Capital Allocation For Filing Of Spac Registration Statement
Allarity Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Allarity Therapeutics Q2 loss narrows as expenses fall
Allarity Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview
Brief: Allarity Therapeutics Announces The Grant Of Essential U.S. Patent For Its Stenoparib Drp® Companion Diagnostic